180302-25-4

Basic information

• Product Name: (3aS,4R,8R,8aS)-4,8-Dibenzyl-6-methoxy-2,2-dimethyl-4,5,8,8a-tetrahydro-3aH-1,3-dioxa-5,7-diaza-azulene
• Synonyms: (3aS,4R,8R,8aS)-4,8-Dibenzyl-6-methoxy-2,2-dimethyl-4,5,8,8a-tetrahydro-3aH-1,3-dioxa-5,7-diaza-azulene
• CAS NO: 180302-25-4
• Molecular Weight: 380.487
• Mol File: 180302-25-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (3aS,4R,8R,8aS)-4,8-Dibenzyl-6-methoxy-2,2-dimethyl-4,5,8,8a-tetrahydro-3aH-1,3-dioxa-5,7-diaza-azulene(CAS DataBase Reference)
• NIST Chemistry Reference: (3aS,4R,8R,8aS)-4,8-Dibenzyl-6-methoxy-2,2-dimethyl-4,5,8,8a-tetrahydro-3aH-1,3-dioxa-5,7-diaza-azulene(180302-25-4)
• EPA Substance Registry System: (3aS,4R,8R,8aS)-4,8-Dibenzyl-6-methoxy-2,2-dimethyl-4,5,8,8a-tetrahydro-3aH-1,3-dioxa-5,7-diaza-azulene(180302-25-4)

Safety Data

• Hazardous Substances Data: 180302-25-4(Hazardous Substances Data)

Upstream product

• 170028-72-5 (3aS,4R,8R,8aS)-4,8-dibenzyl-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-e][1,3]diazepin-6(7H)-one 
• 333-27-7 methyl trifluoromethanesulfonate 
• 1850-14-2 tetramethoxymethane 
• 170870-15-2 (1R,1'R)-1,1'-((4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(2-phenylethanamine) 

Downstream Products

• 1053732-20-9 3-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-N-tert-butyl-benzamide 
• 1054795-51-5 3-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-benzoic acid methyl ester 
• 1053633-34-3 3-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-N-(1H-imidazol-2-yl)-benzamide 
• 1055036-64-0 3-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-N-pyrazin-2-yl-benzamide 
• 1053253-34-1 N-tert-Butyl-3-[(3aS,4R,8R,8aS)-4,8-dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-benzamide 
• 1053629-22-3 3-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-N-(1H-benzoimidazol-2-yl)-benzamide 
• 1053735-60-6 3-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-N-(5-methyl-pyridin-2-yl)-benzamide 
• 1054811-14-1 3-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-N-(1H-imidazol-2-yl)-benzamide 

Relevant articles and documents

Synthesis of unsymmetric cyclic urea diols, a novel class of HIV protease inhibitors

Unsymmetric cyclic urea diols of general structure 1 can be prepared either via an isourea derived from the symmetric diamine 2 or by the selective removal of a benzyl group from certain symmetric cyclic ureas 8, employing dissolving metal reduction.